Agios Pharma (AGIO) Misses Q4 EPS by 10c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.72), $0.10 worse than the analyst estimate of ($1.62). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $7.94 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Deutsche Bank Starts Associated British Foods (ABF:LN) (ASBFY) at Hold
• Adobe (ADBE) PT Lowered to $315 at JPMorgan